Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma Cancer 118
Article first published online: 28 JUN 2011 | DOI: 10.1002/cncr.26255
The results from this study provided data on the usefulness of assessing tumor vascularization in hepatocellular carcinoma with the use of modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. mRECIST characterized a population of 23% of responders who had a significantly better prognosis compared with nonresponding patients.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.